Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ventolin nebulizer vs supportive treatment in transient tachypnea of the newborn
IRCT20091201002801N6Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of salbutamol in transient tachypnea of the newborn (TTN) (2 arms), sponsored by Mazandaran University of Medical Sciences. Started Jul 2023; status: completed.
02
Drugs
salbutamol
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on IRCT20091201002801N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091201002801N6.